H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to humans.
Scientists at UNC Charlotte and MIT used high-performance computational modeling to analyze thousands of viral protein-antibody interactions, revealing a decline in immune response effectiveness. Their research suggests that H5N1 mutations may soon enable human-to-human transmission, raising pandemic concerns. The virus has already spread among wild birds, poultry, cattle, and even farmworkers, emphasizing the need for swift vaccine development.
H5N1's Rapid Evolution Poses a Growing Threat
A research team at the University of North Carolina at Charlotte has used advanced computational modeling to study how the H5N1 bird flu virus interacts with the immune system. Their findings show that the virus is evolving in ways that help it evade immune defenses, whether from past infection or vaccination, in mammals.
Published on March 17 in eBioMedicine (a journal within The Lancet family), the study highlights urgent concerns. As avian influenza continues to spread globally, it poses not only a serious risk to agriculture but also an increasing threat to human health.
Worsening Antibody Affinity Raises Concerns
The researchers found a clear trend: antibodies are becoming less effective against newer strains of H5N1. This "worsening antibody affinity" suggests that future versions of the virus may be even more difficult for the immune system to recognize and fight, raising the risk of transmission to and among humans.
The study's lead author is Colby T. Ford, Ph.D., a visiting scholar in data science at UNC Charlotte's CIPHER center and founder of Tuple, LLC, a biotechnology consulting firm based in Charlotte.
Crucially, Ford explains, this rapid adaptation means that "if one makes an H5N1 vaccine with a previous vaccine candidate virus, the vaccine will have less efficacy, based on our measurements of how much the virus has evolved in recent years" As such, the team's research approach provides guidance for keeping pace with a rapidly adapting viral threat.
The team from UNC Charlotte's Department of Bioinformatics and Genomics includes students Shirish Yasa, Khaled Obeid, and Sayal Guirales-Medrano, led by Bioinformatics Assistant Professor Richard Allen White III, Ph.D., and CIPHER Co-Director Daniel Janies, Ph.D. who is the Carol Grotnes Belk Distinguished Professor of Bioinformatics and Genomics. The UNC Charlotte team collaborated with researchers from the Massachusetts Institute of Technology: Rafael Jaimes III, Ph.D., and Phillip J. Tomezsko, Ph.D.
Antigenic Drift and Increased Zoonotic Risk
By examining the virus' rampant host-shifting and recent mutations comprehensively, researchers find "the continuous transmission of H5N1 from birds to mammals and the increase in strains with immuno-evasive HA in mammals sampled over time suggest that antigenic drift is a source of zoonotic risk."
In the paper, "Large-scale computational modeling of H5 influenza variants against HA1-neutralising antibodies," the UNC Charlotte research team shares their results from analysis of 1,804 viral protein-host antibody comparisons. The experiments consisted of current hemagglutinin domain 1 viral proteins computationally bound in physics models to neutralizing antibodies obtained from infected hosts and vaccine recipients from 1996 to 2018.
Computational Modeling Reveals Alarming Trends
Using high-performance computational modeling, CIPHER researchers documented "a trend of weakening binding affinity of a wide variety of existing antibodies, collected from vaccinated and or infected hosts, against H5 viral isolates over time."
Due to the public health importance, the findings were available via preprint publication in July 2024 prior to successful peer review. Due to the computational tools they had assembled during the SARS-CoV-2 pandemic, the team was able to complete this work on H5N1 just three months after the first reported cow-to-human transmission of H5N1, which was reported in a farmworker in Texas.
In assessing the possible pandemic risk spurred by H5 bird flu spread and mutation, global researchers agree that "the avian virus (remains) high on lists of potential pandemic agents," as reported in Science in December 2024.
H5N1 Cases Surge in Mammals and Poultry
As of this writing, no human-to-human transmission has been reported. However, cattle in at least 17 states have tested positive for H5N1 in addition to millions of cases among wild birds, small mammals, commercial chickens, and other flocks. Between January 2022 and March 2025, the Centers for Disease Control reported:
- 12,510 outbreaks among wild birds in the U.S.
- 51 jurisdictions with bird flu among wild birds.
- 166,417,923 poultry affected
- 70 human cases of H5N1, one fatal, in the U.S.
The H5N1 virus, according to the World Health Organization, has killed 466 people worldwide since January 2003.
Speed Crucial to Combat a Fast-Adapting Virus
Vaccines, many experts say, will likely be a crucial tool in controlling a bird flu pandemic, as mutations of viral lineages adapt to new mammal hosts.
In eBioMedicine, the research team from Charlotte writes that their findings "indicate that the virus has potential to move from epidemic to pandemic status in the near future."
The study – along with other research that confirms worsening antibody binding over time alongside increased avian-to-mammalian transmission – indicates "there is an impending danger to human health for highly pathogenic strains of H5 influenza that can infect avian and mammalian livestock and jump to humans."
Avian Influenza can already be considered a pandemic among wild and domesticated animals due to the virus' pervasive spread across geography and species. Likewise, the spread of H5N1 from wild birds to chickens, dairy cattle, and farm workers illustrates the opportunism of infections across species.
Now, UNC Charlotte's computational modeling results "specifically assert that the worsening trend of the antibody performance along with the already present animal pandemic is a cause for concern for an eventual human pandemic."
Computational Modeling: A Key Tool for Preparedness
Further, the authors write that high-performance computing – which in this case included AI-based protein folding and physics-based simulations of viral protein-antibody interactions – provides rapid and reliable results to inform leaders in preparedness.
Janies, in a recent interview, explained the utility of computational modeling as a means of understanding viral mutation as well as predictive thinking concerning how a virus is evolving.
High-performance computational modeling, Janies said, is a pathway for "chipping away at multiple angles of biological variation at speed and scale" to "tune our intuition to the right approaches" for vaccine efficacy and infection control as viruses evolve.
Reference: "Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies" by Colby T. Ford, Shirish Yasa, Khaled Obeid, Rafael Jaimes, Phillip J. Tomezsko, Sayal Guirales-Medrano, Richard Allen White and Daniel Janies, 17 March 2025, eBioMedicine.
DOI: 10.1016/j.ebiom.2025.105632
The protein modeling research on H5N1 viral lineages conducted at UNC Charlotte was funded by an Ignite grant from the UNC Charlotte Division of Research. Research used genetic data and metadata from GISAID, the Global Initiative on Sharing All Influenza Data, and the United States National Institutes of Health's GenBank.
News
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively “immortal.” Cancer cells face a major problem before they can become deadly: They have to figure out how to stop [...]
How Visual Neurons Organize Thousands of Synaptic Inputs
Summary: A new study uncovered the organizational rules that determine how neurons in the primary visual cortex process information. By imaging both the cell bodies (soma) and the individual synapses (on dendritic spines) of [...]
Scientists Just Found a Surprising Way To Destroy “Forever Chemicals”
Scientists have uncovered a new mechanism that may help break down highly persistent PFAS pollutants. PFAS have earned the nickname “forever chemicals” for a reason. These industrial compounds are so chemically durable that they [...]
Scientists Discover Cheap Material That Kills Deadly Superbugs
A new sulfur-rich antimicrobial polymer shows strong effectiveness against fungal and bacterial pathogens and may offer an affordable solution to antimicrobial resistance. Antimicrobial resistance is creating growing challenges for both healthcare and food production, [...]
What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
Like periodical cicadas, the insects for which it is nicknamed, SARS-CoV-2 Omicron subvariant BA.3.2 is only just beginning to emerge after lying low for an extended period since it first appeared. Although it was [...]
Scientists Say This Simple Supplement May Actually Reverse Heart Disease
Scientists in Japan say a common supplement may actually help “unclog” certain diseased heart arteries from the inside out. A simple food supplement sold in Japan may have helped reverse a dangerous form of [...]
New breakthrough against radiation: Korean Scientists create revolutionary shield with nanotechnology
Korean Scientists develop new nanotechnology material capable of reducing radiation impacts in space missions, hospitals, and power plants. The search for more efficient protection technologies in extreme environments has just gained an important advance. Korean [...]
Scientists Just Discovered the Hidden Trick That Keeps Your Cells Alive
A strange bead-like motion inside cells may be the secret to keeping their DNA—and health—in balance. Mitochondria are often described as the power plants of the cell because they produce the energy cells need [...]
Scientists Discover Stem Cells That Could Regrow Teeth and Bone
Scientists just uncovered the cellular “blueprint” that could one day let us regrow real teeth. Researchers at Science Tokyo have uncovered two distinct stem cell lineages that play a central role in forming tooth [...]
Scientists Uncover Fatal Weakness in “Zombie Cells” Linked to Cancer
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own survival strategy against them. A new class of drugs takes advantage of a recently [...]
Bowel and Ovarian Cancers Are Dramatically Rising in Young Adults, Scientists Aren’t Sure Why
Cancer incidence is increasing, especially among younger adults, and current risk factors don’t fully account for the trend. Scientists suggest other underlying causes may be contributing. Cancer patterns in England are shifting in a [...]
New Immune Pathway Could Supercharge mRNA Cancer Vaccines
A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments. The arrival of mRNA vaccines against SARS-CoV-2 in 2020 marked a turning point in the COVID-19 pandemic. Today, [...]















